Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bio Nobody is going to give Marc any credit .He is crazy and I have never read his posts but I see replies to him and that is what he lives on ,take that away and he is worthless.
Lol.Dont day MRC hate in front of Tasty
Capt great job as usual
Woodcock can’t say no to expansion .She wouldn’t be able to eat her Christmas turkey because of the amount of medical organizations that would be hounding her from Dec29th and that’s not including Amarin’s Legal team .
Judge Judy is the moderator at the Adcom wtf
You saying BP with money will buy some of the Docs on the panel with money or vacations or a free year of V scripts.
Bus I agree with your post but a lot of longs here remember the Adcom 2013 ambush,so yes everyone is on edge.If you are totally confident and buying your tickets for Vegas beter sell now.Im staying all in because I have belief in BHATT[man]and that he have done everything above board for patients and investors.
Atom Everybody got the 5 answers right your the only one that got one wrong
Atom Did the stock crash on the news of the Adcom like you have been calling it for the past month?
IBB flying up /mnkd up 30% in two days .Are we there yet ?
AHA has been a chain around the neck of Amrn since last NOV with the mineral oil crap that took the pps from 22 down to 12.75.Fcuk the AHA and everyone else that is trying to keep Amrn down.
Hi Booze I think the only way to play this stock is LONG and even that could be a risk as we are close to the crossroads with this stock.I hope you make your money back in this stock .Best of luck
BO $200 ?
Another great interview with HCWainright
If the drug is as amazing as you say then no need to go to court.Pps was 23.95 and went dowm to 13s so a lot of big nervous investors.If they can take it down $10 well another 5 dollars would take it to $8.I think the Koolaid gang today talking $200 is premature ejaculation .
Bio if Amrn take the fda to court to fight over label for the next 2 years most of the inst will run and leave Amrn in single digits.No more court cases please.
I agree it’s not going to be a walk I the park.FDA were probably going to give Trigs expansion not CVD and amrn kicked up.Or no malice and they want the panel to decide expansion so nobody dies crossing the road and they were on V.
JL I would take premature ejaculation at my age
Whal Thanks for info .I usually google Mayo if I want info on medicine etc.Its big if they get it moving to patients asap but also good to have going into Adcom
Every you will probably see $12 before you see double $32 so dont go counting your millions yet.This is Amrn
Lemm/Lars is involved in many companies .He is a director of a company 2 doors down from me and it fell 50% last year.He was chief science guy in Elan years ago and he was selling options at $8 before it went to $35 so I wouldnt sweat the small stuff.
Big Vol takes it down and low vol takes it up .No win here till Nov14 .Even with a win in Nov at Adcom these shorts have the shares to take it down .
Shorts control .Rag Doll
10B was mentioned by interviewer and JT did not answer with usual tens of millions .JT did good job ??
Thanks Larry
What did the Doc day about smoking grass on CNBC.Thanks
Turf is on the fireJt feeling the heat.Just don’t say that line Tens of millions .Tick tock
Invest Relax.Jt has the turf on the fire ?? and is ready to give us no news ,so chill out .Big boys betting on 6-5
Against expansion ,well then you can really worry with your 128k shares.
MELL.Irishman Seamus Mulligan bought a drug in 2017 for 500,000 which you inject into people who have overdosed and it takes them back to life.He had no directors in the company and he ended up standing next to Trump at the White House when trump was talking about going heavy on opioids use .The guy sold the drug to another company for 540 million in 2018.Thats the kind of guy we need working V alongside JT.
Trumps sidekick Pent is in a village in ireland meeting his long lost family and hes going to the local pub with his wife and mother for a few pints.Maybe I can get this pps moving before trump gets JLs message.
BUS i get what your saying about IBB down but the IBB was this price when amrn was $23.This not not Amrn following having a bad day with the rest of the market,its about wtf happened @ 23.95.
Cant wait for the BAD news to bring this back into 20s
Whats your point Every?
Bhattman.Thanks Mell for video link.I love the way Bhatt takes control behind a microphone as a lot of intelligent people cant speak or get their message across.I think he will be a big asset when the pressure is on at adcom.
Update of 1 February 2019:
Following the CHMP’s recommendation of 13 December 2018, some of the marketing authorisation
holders involved with this review have requested a re-examination. Upon receipt of the grounds for
their requests, the CHMP will start a re-examination, which is expected to conclude at the CHMP
meeting of 25-29 March 2019.
14 December 2018
Omega-3 fatty acid medicines no longer considered
effective in preventing heart disease
EMA has concluded that omega-3 fatty acid medicines are not effective in preventing further heart and
blood vessels problems in patients who have had a heart attack. The conclusion, based on a review of
data accumulated over the years, means that these medicines will no longer be authorised for such
use.
Omega-3 fatty acid medicines have been authorised for use after a heart attack, in combination with
other medicines, in several EU countries since 2000, at a dose of 1 g per day. At the time of their
authorisation, available data showed some benefits in reducing serious problems with the heart and
blood vessels, although the benefits were considered modest. Further data that have become available
since then have not confirmed the beneficial effects of these medicines for this use.
Although there are no new safety concerns, EMA’s human medicines committee (CHMP) concluded that
the balance between the benefits and risks of these medicines to prevent recurrence of heart disease
or stroke is now negative.
These medicines can still be used to reduce levels of certain types of blood fat called triglycerides.
Information for patients
• Latest data on omega-3 fatty acid medicines show that these medicines are not effective at
preventing further problems with the heart and blood vessels in patients who have had a heart
attack.
• There are alternative treatment options to prevent recurrence of heart problems after a heart
attack.
• If you are using omega-3 fatty acid medicines to reduce the risk of heart problems your doctor will
advise on the best alternative treatment option for you
EMA has confirmed that omega-3 fatty acid medicines containing a combination of an ethyl ester of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) at a dose of 1 g per day are not effective in preventing further problems with the heart and blood vessels in patients who have had a heart attack. This is the outcome of a re-examination requested by some of the companies that market the medicines concerned, following EMA’s original recommendation in December 2018.
This means that these medicines should no longer be used in this way. However, they can still be used to reduce levels of certain types of blood fat called triglycerides.
Omega-3 fatty acid medicines have been authorised for use after a heart attack, in combination with other medicines, in several EU countries since 2000, at a dose of 1 g per day. At the time of their authorisation, available data showed some benefits in reducing serious problems with the heart and blood vessels.
EMA’s committee for human medicines, CHMP, re-assessed the evidence accumulated over the years on these medicines for this specific use and consulted additional experts in the field. It concluded that, although there are no new safety concerns, the effectiveness of these medicines in preventing recurrence of problems with the heart and blood vessels has not been confirmed.
EMA concluded that the marketing authorisations of these medicines should be updated to remove this use
Can you explain your last post as I have been out of the loop for the past week.Whats happening 9/2 to blow the shots away ?Thanks
Thanks Sam .
Rag Doll.Low vol yesterday and shorts come in today and within 20 minutes one mil shorts take it back to $15.
Adcom is all about the FDA wanting to give them lower trigs expansion and amrn want CVD expansion .You could here it in JTs voice when he said he wanted expansion for CVD on Adcom webcast ,he didnt even mention looking for trigs expansion.The Fda are in wars every week ,every month,every year ,so its no big deal going up against Amrn ,its just another company they dont like and are going to throw it around like a WHALE with a baby sea lion.